General and
administrative
expenses (7,379) (1,012) 192 (1) (7,187) (985)
Total operating
expenses (33,806) (4,635) (33,614) (4,608)
Operating income 6,140 841 6,332 868
Other income/
(expenses), net
Interest income 9,048 1,240 9,048 1,240
Interest expense (70) (10) (70) (10)
Grant income 199 27 199 27
Others 299 41 299 41
Total other
income, net 9,476 1,298 9,476 1,298
Income before
Income tax
expense and
minority
interests 15,616 2,139 15,808 2,166
Income tax
credit/
(expense) 2,163 297 (2,739) (2) (576) (79)
Income before
minority
interests 17,779 2,436 15,232 2,087
Minority
interests,
net of tax 116 15 116 16
Net income 17,895 2,451 15,348 2,103
Three Months Ended December 31, 2007
(unaudited), continued
Actual Actual Adjustment Adjusted Adjusted
GAAP GAAP Non-GAAP Non-GAAP
RMB US$ RMB RMB US$
Net income
Per share:
Basic and
diluted 0.12 0.02 0.10 0.01
Basic
weighted
average
number
of shares
outstanding 152,099,155 152,099,155 152,099,155 152,099,155
Effect of
dilutive
potential
shares 323,897 323,897
'/>"/>SOURCE 3SBio Inc. Copyright©2009 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 Related biology technology :1.
3SBio Inc. Receives Official Recognition as a High-Tech Enterprise2.
3SBio Inc. to Report 2008 Fourth Quarter and Full Year Earnings on March 11, 20093.
3SBio Inc. Appoints Mr. Bo Tan as Chief Financial Officer4.
3SBio Inc. to Present at the Piper Jaffray 20th Annual Health Care Conference5.
3SBio Inc. Announces Third Quarter 2008 Results6.
3SBio Inc. Files for SFDA Approval of NuLeusin7.
3SBio Inc. Announces Preliminary Third Quarter 2008 Results8.
3SBio Inc. Schedules 2008 Third Quarter Earnings Release on Monday, November 10, 20089.
3SBio Inc. Files for SFDA Approval of High-dose (36,000 IU) EPIAO10.
3SBio Inc. to Present at the UBS Global Life Sciences Conference11.
3SBio Inc. Announces Results of Annual General Meeting